Rufinamide is a new anti-epileptic drug used as adjunctive treatment of Lennox-Gastaut syndrome. The aim of the study was to give preliminary data about effectiveness and tolerability of rufinamide in a group of patients affected with Lennox-Gastaut syndrome and presenting with refractory seizures.
Risultati preliminari dell’utilizzo di rufinamide in add-on su un campione di soggetti affetti da Sindrome di Lennox-Gastaut.
CIGALA, VIRGINIA;LAMBERTI, MARCO;DI ROSA, GABRIELLA;TORTORELLA, Gaetano
2010-01-01
Abstract
Rufinamide is a new anti-epileptic drug used as adjunctive treatment of Lennox-Gastaut syndrome. The aim of the study was to give preliminary data about effectiveness and tolerability of rufinamide in a group of patients affected with Lennox-Gastaut syndrome and presenting with refractory seizures.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.